Company Healius Limited

Equities

HLS

AU0000033359

Healthcare Facilities & Services

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Group companies

Sector

Sales per Business

Ratings for Healius Limited

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical & Diagnostic Laboratories

Market Closed - Australian S.E. Other stock markets 02:10:52 2024-04-24 am EDT			5-day change	1st Jan Change
1.25 ^AUD	-1.19%		+3.73%	-23.55%

Mar. 06	Morgan Stanley Adjusts Healius’ Price Target to AU$1 From AU$1.30, Keeps at Underweight	MT
Mar. 05	Australia shares inch lower as miners weigh; GDP data in focus	RE

Healius Limited is an Australia-based healthcare company. The Company operates through two segments: Pathology and Imaging. The Pathology segment is a provider of pathology services, including specialty pathology and clinical trials. The Imaging segment is a provider of imaging and scanning services at standalone imaging sites, hospitals, and medical centers. The Company has a network of pathology laboratories, collection centers, and diagnostic imaging centers. It provides specialty diagnostic services to consumers and their referring practitioners. The Companyâs brands include Laverty Pathology, QML Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostics, Abbott Pathology, IQ Pathology, Vetnostics, TML Vetnostics, Agilex Biolabs, Lumus Imaging, and others. The Company provides healthcare services that are accessible and efficient while supporting the coordination and continuity of quality patient care.

Number of employees: 10,500

AUD in Million	2022	Weight	2023	Weight	Delta
Pathology 74.5 %	1,890	80.9 %	1,272	74.5 %	-32.70%
Imaging 25.3 %	394	16.8 %	431	25.3 %	+9.47%
Other 0.2 %	7	0.3 %	4	0.2 %	-40.00%
Intersegment Eliminations 0.0 %	-2	-0.1 %	0	0.0 %	-77.78%
Discontinued Operations 0.0 %	0	0.0 %	0	0.0 %	-

AUD in Million	2022	Weight	2023	Weight	Delta
Australia 100.0 %	2,336	100.0 %	1,707	100.0 %	-26.94%

Managers	Title	Age	Since
Paul Anderson CEO	Chief Executive Officer	-	23-02-28
Stephen Humphries DFI	Director of Finance/CFO	-	20-01-31
Prasad Arav CTO	Chief Tech/Sci/R&D Officer	-	21-03-31
Mark Neeham IRO	Public Communications Contact	-	15-04-30
Janet Payne IRC	Investor Relations Contact	-	15-06-30
Mary Weaver SEC	Corporate Secretary	-	23-03-27

Members of the board	Title	Age	Since
Gordon Davis BRD	Director/Board Member	67	15-08-02
Kathryn McKenzie CHM	Chairman	65	21-02-24
John Mattick BRD	Director/Board Member	-	22-03-30
Michael Stanford BRD	Director/Board Member	65	23-08-31
Ravi Jeyaraj BRD	Director/Board Member	-	Nov. 27
Sally Evans BRD	Director/Board Member	-	18-08-20
Charlie Taylor BRD	Director/Board Member	-	23-03-26

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	726,068,000	636,107,865 ( 87.61 %)	0	87.61 %

Name	Equities	%	Valuation
Perpetual Investment Management Ltd. 13.34 %	96,832,240	13.34 %	84 M $
Australian Retirement Trust Pty Ltd. 9.942 %	72,187,553	9.942 %	62 M $
Tanarra Capital Australia Pty Ltd. 6.778 %	49,211,852	6.778 %	43 M $
Host-Plus Pty Ltd. 6.760 %	49,086,303	6.760 %	42 M $
AUSTRALIAN CLINICAL LABS LIMITED 4.990 %	36,230,451	4.990 %	31 M $
Maple-Brown Abbott Ltd. 4.817 %	34,978,386	4.817 %	30 M $
Dimensional Fund Advisors LP 4.536 %	32,937,077	4.536 %	28 M $
The Vanguard Group, Inc. 4.316 %	31,336,011	4.316 %	27 M $
United Super Pty Ltd. 4.262 %	30,945,858	4.262 %	27 M $
First Sentier Investors (Australia) IM Ltd. 4.209 %	30,563,797	4.209 %	26 M $

Healius Ltd.

Liberty Place 161 Castlereagh Street

2000, Sydney

+61 2 9432 9400

https://www.healius.com.au/

Name	Category and Sector
Specialist Diagnostic Services Pathology (India) Pvt Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Sell

Buy

Mean consensus

UNDERPERFORM

Number of Analysts

Last Close Price

1.265 AUD

Average target price

1.364 AUD

Spread / Average Target

+7.84%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical & Diagnostic Laboratories

	1st Jan change	Capi.
HEALIUS LIMITED	-23.55%	595M
SONIC HEALTHCARE LIMITED	-16.30%	8.36B
RADNET, INC.	+40.44%	3.6B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-29.20%	2.87B
SYNLAB AG	-7.88%	2.47B
DR. LAL PATHLABS LIMITED	-10.78%	2.24B
FLEURY S.A.	-18.40%	1.56B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-39.52%	1.23B
METROPOLIS HEALTHCARE LIMITED	+9.05%	1.13B
ADICON HOLDINGS LIMITED	-17.02%	1.04B

Medical & Diagnostic Laboratories